Fig. 3From: The voltage gated Ca2+-channel Cav3.2 and therapeutic responses in breast cancerCav3.2 upregulation in trastuzumab-resistant cell lines. a Assessment of mRNA levels of 44 calcium pumps, channels and calcium regulating proteins identified increased expression of Cav3.2 in three of four trastuzumab resistant cell lines. All values were measured relative to 18 S rRNA and expressed as −ΔCT. Data points at Y = −20 represent no mRNA detection (n = 3 ± SD). b Acquired resistant cell line RT1 and both intrinsic resistant cell lines (RV1, RV2) showed significantly increased expression of Cav3.2 compared to trastuzumab sensitive age-matched control (SV1) (n = 3 ± SD). Statistical analyses were performed using one-way ANOVA with Bonferroni post-tests (*p ≤ 0.05, **p ≤ 0.01)Back to article page